Suptavumab: A Deep Dive into the REGN2222 Monoclonal Antibody the antibody is a engineered immunoglobulin designed to specifically inhibit IL18, a crucial cytokine implicated in significant respiratory https://www.targetmol.com/compound/suptavumab